Global Down Syndrome Market is Growing with 14.2% CAGR in the Forecast Period of 2021 to 2028

Global Down Syndrome Market is growing with factors such as rising demand for effective therapies. Technological advancements and increasing government support also acts as a major factor for the growth of the market. Rising awareness about the disease has given a boom to the global Down syndrome market.

Growing burden of Down syndrome patients has propelled the demand of the market. However, side effects associated with Down syndrome treatment therapies have decreased the demand of the market.

Global Down Syndrome Market Scenario                                

According to Data Bridge Market Research, the market for Down syndrome in North America has the highest market share followed by Europe and Asia-Pacific. Market leader is F. Hoffmann-La Roche Ltd, which accounts an estimated market share of approximately 26.73% in the global market. The company has gained outstanding sale by providing wide range of Down syndrome product.

  • In January 2020, F. Hoffmann-La Roche Ltd announced the successful strategic collaboration with Atea Pharmaceuticals. It is predicted that this collaboration anticipated enhancing the company’s footprints in the coming years, in turn helping in the growth of the market.

Down Syndrome MarketTrends Impacting the Market  

Now the question is which other regions F. Hoffmann-La Roche Ltd, PerkinElmer Inc. and Illumina, Inc are targeting? Data Bridge Market Research has forecasted a large growth in North America Down syndrome market and the market leaders are targeting the U.S. and Canada to be their next pocket revenue for 2021.

The global Down syndrome market is becoming more competitive with companies like F. Hoffmann-La Roche Ltd, PerkinElmer Inc. and Illumina, Inc .  The Data Bridge Market Research new reports highlight the major growth factors and opportunities in the Down syndrome market.

For more analysis on the global Down syndrome market request for a briefing with our analysts:

Down Syndrome Market Developments

  • In January 2020, F. Hoffmann-La Roche Ltd went under partnership with Illumina. Through this partnership the company has broaden the adoption of advanced and novel diagnostic tools for detection, diagnosis and treatment of several kinds of diseases including Down syndrome among others.

Scope of the Down syndrome market

Global Down syndrome market is segmented on the basis of countries into the U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe, Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt, Rest of Middle East & Africa.

  • All country based analysis of Down syndrome market is further analysed based on further segmentation. On the basis of disease type, the market is segmented into trisomy 21, translocation Down syndrome and mosaic Down syndrome. On the basis of treatment, the market is segmented into diagnosis and treatment. On the basis of end user, the market is segmented into hospitals, clinics, homecare settings, therapy centers and others. On the basis of distribution channel, the market is segmented into direct tenders, retail sales and others. 

To know more about the study:

Key Pointers Covered in Global Down Syndrome Market Industry Trends and Forecast to 2028

  • Market Size
  • Top to Bottom Market Analysis
  • Recent Developments for Market Competitors
  • Recent Market Value for Different Countries
  • Market value and over view of down syndrome market
  • Company profiling of top eight players of down syndrome market

Key Market Competitors Covered in the Report

  • Natera, Inc.
  • Next Biosciences
  • AtilaBiosystems
  • Myriad Genetics, Inc.
  • PerkinElmer Inc.
  • F. Hoffmann-La Roche Ltd
  • Demeditec Diagnostics GmbH’
  • Thermo Fisher Scientific Inc.
  • Abnova Corporation
  • Novus Biologicals (a subsidiary of Bio-Techne)
  • Mayo Clinic Health System
  • Boys Town National Research Hospital
  • Boston Children's Hospital
  • Kid Sense Child Development Corporation Pty Ltd
  • Down Syndrome Cork , a branch of Down Syndrome Ireland
  • Children's Hospital Colorado
  •, Symbol
  • Abbott
  • Illumina, Inc.

Above are the key players covered in the report, to know about more and exhaustive list of Down syndrome, contact us:

Research Methodology: Global Down syndrome Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

  • Demand Side: Manufacturer, Healthcare Industry, Scientists, Research Laboratories
  • Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Related Reports

Browse in Healthcare Category Related Reports@